Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The Swedish company Hamlet Pharma provides new therapeutic solutions using a peptide-based molecular approach for targeting and killing tumor cells with greater precision. With HAMLET and its synthetic drug candidate Alpha1H, the company has an effective cancer drug pipeline with a high degree of selectivity against a variety of cancers. Recent successful outcomes include initial Phase I/II clinical trial data, proving that Al...
The Swedish company Hamlet Pharma provides new therapeutic solutions using a peptide-based molecular approach for targeting and killing tumor cells with greater precision. With HAMLET and its synthetic drug candidate Alpha1H, the company has an effective cancer drug pipeline with a high degree of selectivity against a variety of cancers. Recent successful outcomes include initial Phase I/II clinical trial data, proving that Alpha1H acts with high efficacy without any detectable toxicity.

List your booth number for exhibitions, ask us